What it is used for
LINZESS is indicated for the treatment of: • irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients 7 years of age and older • chronic idiopathic constipation (CIC) in adults • functional constipation (FC) in pediatric patients 2 years of age and older LINZESS is a guanylate cyclase-C agonist indicated for treatment of: Irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients 7 years of age and older. Chronic idiopathic constipation (CIC) in adults. Functional constipation (FC) in pediatric patients 2 years of age and older.
⚠️ Drug Interactions (1 records)
FDA Data
🟡 Moderate
No interactions listed
✓ Verified · Source: openFDA